Company Filing History:
Years Active: 2024-2025
Title: Viresh Mohanlall: Innovator in Anticancer and Antitubercular Research
Introduction
Viresh Mohanlall is a notable inventor based in Durban, South Africa. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating serious diseases such as cancer and tuberculosis. With a total of two patents to his name, Mohanlall is recognized for his innovative approaches to drug development.
Latest Patents
Mohanlall's latest patents include "Ethyl-1-(substitutedbenzoyl)-5-methylpyrrolo[1,2-a]quinoline-3-carboxylates as anticancer agents." This patent outlines methods of treating cancer in patients by administering these specific compounds. Another significant patent is for "Substituted 1,4-dihydropyrimidines as antitubercular agents," which focuses on compounds for treating tuberculosis, particularly those that are substituted 1,4-dihydropyrimidines and their use as anti-tubercular agents.
Career Highlights
Viresh Mohanlall is affiliated with King Fahd University of Petroleum and Minerals, where he continues to engage in research and development. His work is characterized by a commitment to finding effective treatments for critical health issues.
Collaborations
Mohanlall has collaborated with notable colleagues such as Katharigatta N Venugopala and Vijaykumar Uppar. These collaborations have likely contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Viresh Mohanlall stands out as an innovative inventor in the field of medicinal chemistry, with a focus on developing effective treatments for cancer and tuberculosis. His contributions through patents reflect his dedication to improving health outcomes through scientific research.